Published in Maroc Med on June 01, 1955
[Radioactive sodium Na24 and cerebrospinal fluid; applications to the diagnosis of tuberculous meningitis and spinal cord compression]. Rev Neurol (Paris) (1951) 1.48
SUCCESSFUL ALLOGENIC BONE MARROW TRANSPLANTATION IN MAN: CHIMERISM, INDUCED SPECIFIC TOLERANCE AND POSSIBLE ANTI-LEUKEMIC EFFECTS. Blood (1965) 1.07
[Cancer of the thyroid treated with radioactive iodine; termination by acute leukemia after an important amelioration]. Bull Assoc Fr Etud Cancer (1953) 0.98
[Studies on the growth of BCG bacillus in the presence of radioactive phosphorus]. Ann Inst Pasteur (Paris) (1953) 0.96
[Nanism caused by incomplete hypothyroidism]. Sem Hop (1957) 0.93
[Determination of the time of renewal of natural thyroid hormone labelled with radioiodine in rabbit and in man]. C R Seances Soc Biol Fil (1951) 0.90
[CURRENT DATA ON THE RISKS FOR THE EMBRYO, FETUS AND CHILD OF MEDICAL RADIOLOGY. DESCRIPTION OF MEASURES ALREADY CARRIED OUT TO AVOID THEM. SUGGESTIONS ON MEASURES TO BE TAKEN]. Rev Hyg Med Soc (1963) 0.86
[Results of examination of 85 cases of cancer of the thyroid with radioactive iodine]. J Radiol Electrol Arch Electr Medicale (1951) 0.85
[Plasmatic iron & synthesis of hemoglobin]. Sang (1958) 0.85
[Not Available]. Bull Assoc Fr Etud Cancer (1957) 0.84
THYROIDAL IODOPROTEINS IN PATIENTS WITH GOITROUS HYPOTHYROIDISM. J Clin Endocrinol Metab (1964) 0.84
[The outcome of essential polyglobulia treated with radioactive phosphorus. Apropos of a series of 310 cases]. Nouv Rev Fr Hematol (1961) 0.84
[PRESENT STATUS OF OUR EXPERIENCE WITH LIVER TRANSPLANTATION IN ANIMALS]. Mem Acad Chir (Paris) (1965) 0.83
[The penetration of iron in red cells in vitro]. C R Hebd Seances Acad Sci (1955) 0.83
NEW METHODS OF TREATMENT IN RADIATION THERAPY. Clin Radiol (1964) 0.83
[Characteristics of abnormal thyroglobulin extracted from certain congenital goiters with disorders of homonogenesis]. Rev Fr Etud Clin Biol (1959) 0.82
[Effect of bleeding on erythropoiesis and iron metabolism in irradiated mice]. Rev Fr Etud Clin Biol (1959) 0.80
Total body irradiation for organ transplantation. Proc R Soc Med (1961) 0.79
[Treatment of thrombocythemia by radiophosphorus]. Sang (1957) 0.79
[TECHNIC OF STUDYING ERYTHROPOIESIS USING RADIOACTIVE IRON]. Rev Fr Etud Clin Biol (1965) 0.78
[Modification of erythropoiesis after pelvic radiotherapy]. Acta radiol (1959) 0.78
[Research on anemia in acute leukosis. I. Iron metabolism in acute leukosis studies with Fe59]. Rev Hematol (1954) 0.78
[Anemia in acute leukosis]. Sem Hop (1955) 0.77
[HEMATOLOGIC COURSE OF PATIENTS SUBJECTED TO TOTAL-BODY IRRADIATION FOR ORGAN TRANSPLANTATION]. Ann Radiol (Paris) (1963) 0.77
[Hypothyroidism caused by a congenital abnormality in thyroxin synthesis]. Rev Fr Etud Clin Biol (1958) 0.76
[Study of the distribution of radiophosphorus (P 32) by external measurement of Brehmstrahlung]. C R Hebd Seances Acad Sci (1958) 0.75
[Use of radioiodine 132 in thyroid function tests in children]. Minerva Nucl (1958) 0.75
[Preliminary study of scintillation dosimetry in radium therapy]. J Radiol Electrol Arch Electr Medicale (1956) 0.75
[Not Available]. Bull Assoc Fr Etud Cancer (1954) 0.75
[Effect of intraperitoneal radioactive colloidal gold injection on the parenchyma of rat livers; induction of cholangiomas]. Bull Assoc Fr Etud Cancer (1955) 0.75
[Not Available]. J Radiol Electrol Arch Electr Medicale (1955) 0.75
[The concept of relative biological effectiveness (Its place among the concepts and units utilized in radiology)]. J Radiol Electrol Med Nucl (1960) 0.75
[Not Available]. Rev Med Chir Mal Foie (1956) 0.75
[Utilisation des isotopes radioactifs en cancerologie]. Acta Unio Int Contra Cancrum (1954) 0.75
[In vitro study of hemin synthesis in bone marrow erythroblasts]. Ann Biol Clin (Paris) (1957) 0.75
[Problems of dosimetry posed by the utilization of radioactive iodine in the treatment of cancer of the thyroid]. J Radiol Electrol Arch Electr Medicale (1954) 0.75
[Evaluation of thyroid function by radioactive iodine in human clinical medicine: comparison of the results furnished by two simple tests]. Bull Acad Natl Med (1955) 0.75
[Not Available]. Bull Assoc Fr Etud Cancer (1957) 0.75
[Compensatory hyperfunctioning of the thyroid isthmus after double lobectomy]. C R Hebd Seances Acad Sci (1958) 0.75
[Practical problems of dosimetry presented by utilization of radioelements. I. Doses or proximity of a sphere]. J Radiol Electrol Arch Electr Medicale (1954) 0.75
[The progress of cancer therapy]. Lutte Cancer (1955) 0.75
[Nanism caused by incomplete hypothyroidism]. Bull Mem Soc Med Hop Paris (1956) 0.75
[Distribution of colloidal gold 198 in interstitial injection into healthy cellular subcutaneous tissue]. J Radiol Electrol Arch Electr Medicale (1957) 0.75
[Study of the distribution of radioactive iron in the mouse by anatomical radioautography at -195 degrees C]. C R Hebd Seances Acad Sci (1959) 0.75
[Action of radioactive phosphorus on essential polyglobulism and excessive number of platelets; 82 personal cases]. Presse Med (1955) 0.75
[Protective role of cortisone against the aplastic effects of methyl bis (beta-chlorethyl) amine on the bone marrow of the rat]. C R Seances Soc Biol Fil (1956) 0.75
[Results of examinations utilizing radioactive iodine in treated hyperthyroid patients]. Pathol Biol (Paris) (1959) 0.75
[Radioactive iodine and thyroid heterogenicity]. J Physiol (Paris) (1957) 0.75
[Study of the distribution of radiophosphorus (P32) by the external measurement of deceleration radiations]. Rev Fr Etud Clin Biol (1958) 0.75
[Importance of high-energy radiotherapy, alone & with surgery, in the treatment of bronchial cancer]. Sem Hop (1958) 0.75
[Study of various aspects of metabolism of thyroxin in humans]. J Physiol (Paris) (1956) 0.75
[Protective action of beta-mercaptoethylamine against methylbis(beta-chlorethyl)amine in rats]. C R Seances Soc Biol Fil (1956) 0.75
[Ionizing radiations in pneumological practice (radiodiagnosis & radiodetection)]. Bull Acad Natl Med (1958) 0.75
[Technical conditions for irradiation of cancers of the bladder by transcutaneous high energy radiotherapy]. J Radiol Electrol Arch Electr Medicale (1959) 0.75
[Metabolism of radioiodine labeled thyroxin in man after injection of physiological and pharmacodynamic doses]. Ann Endocrinol (Paris) (1955) 0.75
[Three thousand radioiodine thyroid function tests]. Presse Med (1958) 0.75
[Production of malignant tumors (hepatomas and others) by intraperitoneal injections of radioactive gold in the white rat]. Bull Assoc Fr Etud Cancer (1957) 0.75
[Treatment of tumors of the lung and esophagus by betatron]. Minerva Nucl (1958) 0.75
[Treatment of thrombocythemia and polyglobulism with radiophosphorus]. J Radiol Electrol Arch Electr Medicale (1958) 0.75
[Examination of the thyroid by drilling puncture; measurement of radioactivity and autography of removed substance]. Ann Endocrinol (Paris) (1953) 0.75
[Inhibition of hemoglobin synthesis in vitro by beta-chloroethyl compounds]. C R Hebd Seances Acad Sci (1956) 0.75
[Palliative treatment of malignant pleural effusions with intrapleural injection of colloidal radioactive gold]. J Fr Med Chir Thorac (1956) 0.75
[Atomic traumatism]. Rev Prat (1954) 0.75
[The therapeutic use of radioiodine]. Rev Prat (1958) 0.75
[Functional heterogeneity of thyroid iodine demonstrated by isotope studies]. Prog Nucl Energy 6 Biol Sci (1958) 0.75
[Effect of the selective irradiation of the spleen on Fe59 metabolism in rats]. C R Seances Soc Biol Fil (1956) 0.75
[Comparative splenic lesions secondary to selective local irradiation of the spleen to total body irradiation with x-rays in rats]. C R Hebd Seances Acad Sci (1955) 0.75
[Use of radioactive isotopes in external betatherapy]. J Radiol Electrol Arch Electr Medicale (1958) 0.75
[Study of thyroid function in the child with radioactive iodine]. Pathol Biol (Paris) (1959) 0.75
[Radioactive iodine and the thyroid]. Rev Prat (1958) 0.75
[Centering procedures in deep radiotherapy by transcutaneous route]. J Radiol Electrol Arch Electr Medicale (1955) 0.75
[Splenic lesions induced in the rat by segmental or global irradiation of the organism, or by selective irradiation of the spleen]. J Radiol Electrol Arch Electr Medicale (1958) 0.75
[Corrections for heterogeneity in Co60 clusters]. J Radiol Electrol Arch Electr Medicale (1959) 0.75
[Arsenic 76 fixation in the skin in various malignant types of erythroderma]. Bull Assoc Fr Etud Cancer (1954) 0.75
[Comparison between 2 groups of cancers of thoracic esophagus treated by 200kV radiotherapy & high energy radiotherapy (betatron, 22 MeV)]. Arch Mal Appar Dig Mal Nutr (1959) 0.75
[Hematological changes secondary to treatment of thyroid cancers by strong doses of radioactive iodine]. J Radiol Electrol Arch Electr Medicale (1959) 0.75
[Study of 54 cases of cancer of the thoracic esophagus treated by betatron (22 MeV)]. J Radiol Electrol Arch Electr Medicale (1958) 0.75
[Experimental study of lesions induced by intracerebral radiogold implant; therapeutic implications]. Rev Neurol (Paris) (1954) 0.75
[Marking and centering procedures in transcutaneous deep radiotherapy]. J Radiol Electrol Arch Electr Medicale (1955) 0.75
[Preliminary results of the treatment of neoplastic effusions with radioactive gold]. Bull Assoc Fr Etud Cancer (1953) 0.75
[Measurement of erythrocyte formation in man using radioactive chromium]. Rev Hematol (1958) 0.75
[Congenital hypothyroidism with goiter caused by defect in conversion of inorganic iodine to organic iodine]. Rev Fr Etud Clin Biol (1959) 0.75
[Results of 500 tests of intra-thyroid fixation of radioactive iodine in children]. Ann Endocrinol (Paris) (1956) 0.75
[Splenic lesions induced by selective irradiation of the spleen, partial or total irradiation of the organism]. Sang (1956) 0.75
[Experimental studies on the toxicology of benzene; changes of erythropoiesis followed by radioactive iron]. Arch Mal Prof (1959) 0.75
[Not Available]. Rev Fr Etud Clin Biol (1956) 0.75
[Technical conditions in irradiation of bronchial cancers with the betatron (22 MeV)]. J Radiol Electrol Arch Electr Medicale (1958) 0.75
[Importance of transverse tomography (horizontal strata) in marking, centering and dosimetry of thoracic tumors treated by transcutaneous radiotherapy]. J Radiol Electrol Arch Electr Medicale (1955) 0.75
[Use of radioactive isotopes in cancerology]. Maroc Med (1955) 0.75
[Sporadic goitrous cretinism caused by congenital abnormality in thyroid hormone synthesis; 2 case reports]. Sem Hop (1958) 0.75
[Do radiological examinations present a risk?]. Rev Fr Etud Clin Biol (1959) 0.75
[Inhibition of hemoglobin metabolism in reticulocytes by beta-chloroethyl compounds]. C R Seances Soc Biol Fil (1956) 0.75
[Physiopathologic studies on myeloid splenomegaly with myelofibrosis; studies with radioactive iron and chromium]. Rev Hematol (1958) 0.75
[Decisive progress in telecurietherapy; telecobalttherapy]. J Radiol Electrol Arch Electr Medicale (1955) 0.75
[Results of 3000 thyroid function tests using radioactive iodine]. Minerva Nucl (1958) 0.75
[Use of radioactive isotopes in diagnosis and treatment of non-cancerous diseases]. Maroc Med (1955) 0.75
[Comparison of survival between two series of bronchial cancer treated by 5500 and 7500 rads]. J Radiol Electrol Arch Electr Medicale (1959) 0.75
[Not Available]. Therapie (1957) 0.75
[Placing of a patient in sitting position for transcutaneous irradiation (betatron 22 MeV)]. J Radiol Electrol Arch Electr Medicale (1959) 0.75
[Practical problems of dosimetry. II. Role of diffusion in therapeutic use of radio-elements]. J Radiol Electrol Arch Electr Medicale (1956) 0.75